Skip to main content

Starling Oncology, Inc 10-K for FY2021

Starling Oncology, Inc. (STLN)

10-K 2022-03-11 For: 2021-12-31
View Original
Added on April 06, 2026

About this 10-K

Starling Oncology, Inc filed this 10-K on March 11, 2022, covering the fiscal year ended December 31, 2021 (FY2021).

Headline figures

Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$203M
up 8.3% from $187.52M a year earlier
Net loss
$10.93M
compared with a net loss of $14.32M a year earlier
Diluted EPS
-$0.16
compared with -$0.24 a year earlier